{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:00:23Z","timestamp":1790744423377,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T00:00:00Z","timestamp":1482796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010116","name":"Medicinska Underst\u00f6dsf\u00f6reningen Liv och H\u00e4lsa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007247","name":"Svenska Kulturfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["grant 545902"],"award-info":[{"award-number":["grant 545902"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001250","name":"Transport Accident Commission","doi-asserted-by":"publisher","award":["D162"],"award-info":[{"award-number":["D162"]}],"id":[{"id":"10.13039\/501100001250","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00134-016-4655-2","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T02:16:31Z","timestamp":1482804991000},"page":"419-428","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Venous thromboembolic events in critically ill traumatic brain injury patients"],"prefix":"10.1007","volume":"43","author":[{"name":"For the EPO-TBI investigators and the ANZICS Clinical Trials Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus B.","family":"Skrifvars","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Presneill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Duranteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Huet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaseen","family":"Arabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. James","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinaldo","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,27]]},"reference":[{"key":"4655_CR1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1055\/s-0033-1343356","volume":"39","author":"HA Phelan","year":"2013","unstructured":"Phelan HA (2013) Venous thromboembolism after traumatic brain injury. Semin Thromb Hemost 39:541\u2013548","journal-title":"Semin Thromb Hemost"},{"key":"4655_CR2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13054-015-0814-z","volume":"19","author":"H Abdel-Aziz","year":"2015","unstructured":"Abdel-Aziz H, Dunham CM, Malik RJ, Hileman BM (2015) Timing for deep vein thrombosis chemoprophylaxis in traumatic brain injury: an evidence-based review. Crit Care 19:96","journal-title":"Crit Care"},{"key":"4655_CR3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s00134-011-2139-y","volume":"37","author":"H Lier","year":"2011","unstructured":"Lier H, Bottiger BW, Hinkelbein J, Krep H, Bernhard M (2011) Coagulation management in multiple trauma: a systematic review. Intensive Care Med 37:572\u2013582","journal-title":"Intensive Care Med"},{"key":"4655_CR4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/bja\/aeq254","volume":"105","author":"KM Ho","year":"2010","unstructured":"Ho KM, Burrell M, Rao S, Baker R (2010) Incidence and risk factors for fatal pulmonary embolism after major trauma: a nested cohort study. Br J Anaesth 105:596\u2013602","journal-title":"Br J Anaesth"},{"key":"4655_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jamcollsurg.2015.10.014","volume":"222","author":"CJ Allen","year":"2016","unstructured":"Allen CJ, Murray CR, Meizoso JP, Ginzburg E, Schulman CI, Lineen EB, Namias N, Proctor KG (2016) Surveillance and early management of deep vein thrombosis decreases rate of pulmonary embolism in high-risk trauma patients. J Am Coll Surg 222:65\u201372","journal-title":"J Am Coll Surg"},{"key":"4655_CR6","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM199412153312401","volume":"331","author":"WH Geerts","year":"1994","unstructured":"Geerts WH, Code KI, Jay RM, Chen E, Szalai JP (1994) A prospective study of venous thromboembolism after major trauma. N Engl J Med 331:1601\u20131606","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"4655_CR7","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1089\/neu.2007.9991","volume":"24","author":"SL Bratton","year":"2007","unstructured":"Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care, AANS\/CNS, Bratton SL, Chestnut RM, Ghajar J, McConnell Hammond FF, Harris OA, Hartl R, Manley GT, Nemecek A, Newell DW, Rosenthal G, Schouten J, Shutter L, Timmons SD, Ullman JS, Videtta W, Wilberger JE, Wright DW (2007) Guidelines for the management of severe traumatic brain injury. V. Deep vein thrombosis prophylaxis. J Neurotrauma 24(Suppl 1):S32\u2013S36","journal-title":"J Neurotrauma"},{"key":"4655_CR8","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/S0140-6736(15)00386-4","volume":"386","author":"A Nichol","year":"2015","unstructured":"Nichol A, French C, Little L, Haddad S, Presneill J, Arabi Y, Bailey M, Cooper DJ, Duranteau J, Huet O, Mak A, McArthur C, Pettila V, Skrifvars M, Vallance S, Varma D, Wills J, Bellomo R, EPO-TBI Investigators, ANZICS Clinical Trials Group (2015) Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial. Lancet 386:2499\u20132506","journal-title":"Lancet"},{"key":"4655_CR9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13063-014-0528-6","volume":"16","author":"A Nichol","year":"2015","unstructured":"Nichol A, French C, Little L, Presneill J, Cooper DJ, Haddad S, Duranteau J, Huet O, Skrifvars M, Arabi Y, Bellomo R, EPO-TBI Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group (2015) Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trial. Trials 16:39","journal-title":"Trials"},{"key":"4655_CR10","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJMoa071533","volume":"357","author":"HL Corwin","year":"2007","unstructured":"Corwin HL, Gettinger A, Fabian TC, May A, Pearl RG, Heard S, An R, Bowers PJ, Burton P, Klausner MA, Corwin MJ, EPO Critical Care Trials Group (2007) Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 357:965\u2013976","journal-title":"N Engl J Med"},{"key":"4655_CR11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jama.2014.6490","volume":"312","author":"CS Robertson","year":"2014","unstructured":"Robertson CS, Hannay HJ, Yamal JM, Gopinath S, Goodman JC, Tilley BC, Epo Severe TBITI, Baldwin A, Rivera Lara L, Saucedo-Crespo H, Ahmed O, Sadasivan S, Ponce L, Cruz-Navarro J, Shahin H, Aisiku IP, Doshi P, Valadka A, Neipert L, Waguspack JM, Rubin ML, Benoit JS, Swank P (2014) Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA 312:36\u201347","journal-title":"JAMA"},{"key":"4655_CR12","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","volume":"355","author":"AK Singh","year":"2006","unstructured":"Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D, Investigators C (2006) Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355:2085\u20132098","journal-title":"N Engl J Med"},{"key":"4655_CR13","first-page":"912","volume":"68","author":"AP Ekeh","year":"2010","unstructured":"Ekeh AP, Dominguez KM, Markert RJ, McCarthy MC (2010) Incidence and risk factors for deep venous thrombosis after moderate and severe brain injury. J Trauma 68:912\u2013915","journal-title":"J Trauma"},{"key":"4655_CR14","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/CCM.0b013e3181c9ccc8","volume":"38","author":"TL Ortel","year":"2010","unstructured":"Ortel TL (2010) Acquired thrombotic risk factors in the critical care setting. Crit Care Med 38:S43\u2013S50","journal-title":"Crit Care Med"},{"key":"4655_CR15","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1097\/TA.0b013e31817fdf1c","volume":"66","author":"DA Reiff","year":"2009","unstructured":"Reiff DA, Haricharan RN, Bullington NM, Griffin RL, McGwin G Jr, Rue LW 3rd (2009) Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis. J Trauma 66:1436\u20131440","journal-title":"J Trauma"},{"key":"4655_CR16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.sla.0000137138.40116.6c","volume":"240","author":"MM Knudson","year":"2004","unstructured":"Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS (2004) Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg 240:490\u2013496 (discussion 496-498)","journal-title":"Ann Surg"},{"key":"4655_CR17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/1745-6215-15-501","volume":"15","author":"J Presneill","year":"2014","unstructured":"Presneill J, Little L, Nichol A, French C, Cooper DJ, Haddad S, Duranteau J, Huet O, Skrifvars M, Arabi Y, Bellomo R, EPO-TBI Investigators, ANZICS Clinical Trials Group (2014) Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury. Trials 15:501","journal-title":"Trials"},{"key":"4655_CR18","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa1014475","volume":"364","author":"D Cook","year":"2011","unstructured":"PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group, Cook D, Meade M et al (2011) Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med 364:1305\u20131314","journal-title":"N Engl J Med"},{"key":"4655_CR19","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00134-014-3442-1","volume":"40","author":"P Garcia-Olivares","year":"2014","unstructured":"Garcia-Olivares P, Guerrero JE, Galdos P, Carriedo D, Murillo F, Rivera A (2014) PROF-ETEV study: prophylaxis of venous thromboembolic disease in critical care units in Spain. Intensive Care Med 40:1698\u20131708","journal-title":"Intensive Care Med"},{"key":"4655_CR20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.107.709204","volume":"117","author":"W Ageno","year":"2008","unstructured":"Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW (2008) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 117:93\u2013102","journal-title":"Circulation"},{"issue":"93\u2013100","key":"4655_CR21","first-page":"107","volume":"11","author":"RP Tracy","year":"2002","unstructured":"Tracy RP (2002) Hemostatic and inflammatory markers as risk factors for coronary disease in the elderly. Am J Geriatr Cardiol 11(93\u2013100):107","journal-title":"Am J Geriatr Cardiol"},{"key":"4655_CR22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0047-6374(93)90039-T","volume":"71","author":"D Kasjanovova","year":"1993","unstructured":"Kasjanovova D, Adameckova D, Gratzlova J, Hegyi L (1993) Sex-related and age-related differences in platelet function in vitro: influence of hematocrit. Mech Ageing Dev 71:103\u2013109","journal-title":"Mech Ageing Dev"},{"key":"4655_CR23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/000331979504600810","volume":"46","author":"G Gleerup","year":"1995","unstructured":"Gleerup G, Winther K (1995) The effect of ageing on platelet function and fibrinolytic activity. Angiology 46:715\u2013718","journal-title":"Angiology"},{"key":"4655_CR24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/01.HYP.38.2.274","volume":"38","author":"S Taddei","year":"2001","unstructured":"Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, Salvetti A (2001) Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38:274\u2013279 (Dallas, Tex: 1979)","journal-title":"Hypertension"},{"key":"4655_CR25","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/CCM.0b013e3181c9cbd9","volume":"38","author":"I Martinelli","year":"2010","unstructured":"Martinelli I, Bucciarelli P, Mannucci PM (2010) Thrombotic risk factors: basic pathophysiology. Crit Care Med 38:S3\u2013S9","journal-title":"Crit Care Med"},{"key":"4655_CR26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.thromres.2007.09.010","volume":"122","author":"M Franchini","year":"2008","unstructured":"Franchini M, Targher G, Montagnana M, Lippi G (2008) The metabolic syndrome and the risk of arterial and venous thrombosis. Thromb Res 122:727\u2013735","journal-title":"Thromb Res"},{"key":"4655_CR27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/000313481508100625","volume":"81","author":"JM Nunez","year":"2015","unstructured":"Nunez JM, Becher RD, Rebo GJ, Farrah JP, Borgerding EM, Stirparo JJ, Lauer C, Kilgo P, Miller PR (2015) Prospective evaluation of weight-based prophylactic enoxaparin dosing in critically Ill trauma patients: adequacy of antixa levels is improved. Am Surg 81:605\u2013609","journal-title":"Am Surg"},{"key":"4655_CR28","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jamasurg.2016.1662","volume":"151","author":"A Ko","year":"2016","unstructured":"Ko A, Harada MY, Barmparas G, Chung K, Mason R, Yim DA, Dhillon N, Margulies DR, Gewertz BL, Ley EJ (2016) Association between enoxaparin dosage adjusted by anti-factor Xa trough level and clinically evident venous thromboembolism after trauma. JAMA Surg 151:1006\u20131013","journal-title":"JAMA Surg"},{"key":"4655_CR29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1055\/s-0030-1247890","volume":"27","author":"H Aryafar","year":"2010","unstructured":"Aryafar H, Kinney TB (2010) Optional inferior vena cava filters in the trauma patient. Semin Intervent Radiol 27:68\u201380","journal-title":"Semin Intervent Radiol"},{"key":"4655_CR30","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00134-015-3840-z","volume":"41","author":"S Beitland","year":"2015","unstructured":"Beitland S, Sandven I, Kj\u00e6rvik LK, Sandset PM, Sunde K, Eken T (2015) Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-anlaysis and trial sequential analysis. Intensive Care Med 41:1209\u20131219","journal-title":"Intensive Care Med"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-016-4655-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-016-4655-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-016-4655-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T04:00:48Z","timestamp":1601265648000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-016-4655-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,27]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["4655"],"URL":"https:\/\/doi.org\/10.1007\/s00134-016-4655-2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727149851.793526986","asserted-by":"object"}]},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,27]]}}}